MDT 📈 Medtronic - Overview

Exchange: NYSE • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00BTN1Y115

MDT: Cardiac Devices, Neurological Implants, Surgical Instruments, Insulin Pumps

Medtronic plc is a global leader in developing, manufacturing, and selling innovative medical devices and therapies that improve the lives of millions of people worldwide. The company's Cardiovascular Portfolio segment is dedicated to providing life-changing solutions for heart patients, including implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. Additionally, they offer a range of products for cardiac ablation, insertable cardiac monitoring, and remote patient monitoring, as well as aortic valves, surgical valve replacement and repair products, and transcatheter pulmonary valves.

The Neuroscience Portfolio segment focuses on providing medical devices and implants, biologic solutions, and interventional products for a wide range of medical specialties, including spinal surgeons, neurosurgeons, neurologists, pain management specialists, and orthopedic surgeons. Their products include spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and nerve ablation systems, as well as energy surgical instruments.

The Medical Surgical Portfolio segment offers a broad range of surgical solutions, including surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, and AI-powered surgical video and analytics platforms. They also provide robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, and gastrointestinal and hepatologic diagnostics and therapies. Furthermore, they offer patient monitoring and airway management products to support healthcare professionals in providing high-quality care.

The Diabetes Operating Unit segment is dedicated to improving the lives of people with diabetes, offering innovative products such as insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. With a rich history dating back to 1949, Medtronic plc is headquartered in Galway, Ireland, and continues to drive innovation and advancements in medical technology. To learn more, visit their website at https://www.medtronic.com.

Additional Sources for MDT Stock

MDT Stock Overview

Market Cap in USD 112,510m
Sector Healthcare
Industry Medical Devices
GiC Industry Health Care Equipment & Supplies
TER 0.00%
IPO / Inception 1978-01-13

MDT Stock Ratings

Growth 5y -19.0%
Fundamental 28.4%
Dividend 61.6%
Rel. Performance Sector -0.14
Analysts 3.76/5
Fair Price Momentum 80.83 USD
Fair Price DCF 103.78 USD

MDT Dividends

Dividend Yield 12m 3.24%
Yield on Cost 5y 2.82%
Annual Growth 5y 5.34%
Payout Consistency 97.78%

MDT Growth Ratios

Growth Correlation 3m -40.2%
Growth Correlation 12m 48.8%
Growth Correlation 5y -53.9%
CAGR 5y -2.74%
CAGR/Mean DD 5y -0.12
Sharpe Ratio 12m 0.50
Alpha -18.05
Beta 0.88
Volatility 19.34%
Current Volume 4979.4k
Average Volume 20d 7053k
What is the price of MDT stocks?
As of December 04, 2024, the stock is trading at USD 85.71 with a total of 4,979,401 shares traded.
Over the past week, the price has changed by +0.04%, over one month by -4.03%, over three months by -2.89% and over the past year by +11.10%.
Is Medtronic a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Medtronic is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.38 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MDT as of December 2024 is 80.83. This means that MDT is currently overvalued and has a potential downside of -5.69%.
Is MDT a buy, sell or hold?
Medtronic has received a consensus analysts rating of 3.76. Therefor, it is recommend to hold MDT.
  • Strong Buy: 11
  • Buy: 6
  • Hold: 14
  • Sell: 1
  • Strong Sell: 1
What are the forecast for MDT stock price target?
According to ValueRays Forecast Model, MDT Medtronic will be worth about 88.4 in December 2025. The stock is currently trading at 85.71. This means that the stock has a potential upside of +3.15%.
Issuer Forecast Upside
Wallstreet Target Price 96.1 12.1%
Analysts Target Price 90.4 5.5%
ValueRay Target Price 88.4 3.2%